Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 1 (2 Fluorophenyl)ethanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106047950A details enzymatic reduction for high-purity intermediates. Offers cost reduction and scalable supply chain solutions for global pharmaceutical manufacturing.
Patent CN107794282B reveals a high-yield biocatalytic route for Crizotinib intermediates using Geotrichum candidum, offering superior purity and cost efficiency for API manufacturing.
Patent CN106701698B reveals high-efficiency SsCR enzyme for chiral alcohol synthesis. Achieves 99.9% ee and 500mmol/L substrate concentration for scalable manufacturing.
Patent CN103319311A details a high-efficiency iridium-catalyzed route for (1S)-1-(2,6-dichloro-3-fluorophenyl)ethanol, offering superior ee values and scalability for API production.
Reduce supply chain risks with metal-free deracemization process. 90%+ yield, 95% ee, and scalable production for chiral alcohol intermediates.